|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aguiar PN Jr, Tadokoro H, Forones NM and
de Mello RA: Treating operable patients with gastric cancer:
Macdonald's protocol versus adjuvant chemotherapy. Future Oncol.
11:2247–2249. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neumann L, Pforr C, Beaudouin J, Pappa A,
Fricker N, Krammer PH, Lavrik IN and Eils R: Dynamics within the
CD95 death-inducing signaling complex decide life and death of
cells. Mol Syst Biol. 6:3522010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laytragoon-Lewin N, Jönson F, Lundgren J,
Lundgren J, Rutqvist LE, Wikby A, Löfgren S and Lewin F: Perforin,
CD28 and CD95 expression in circulating CD4 and CD8 cells as
predictors of head and neck (H&N) cancer patient survival. Med
Oncol. 31:2902014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He C, Jiang H, Geng S, Sheng H, Shen X,
Zhang X, Zhu S, Chen X, Yang C and Gao H: Expression and prognostic
value of c-Myc and Fas (CD95/APO1) in patients with pancreatic
cancer. Int J Clin Exp Pathol. 7:742–750. 2014.PubMed/NCBI
|
|
6
|
Wang L, Pan XD, Xie Y, Zhang GB, Jiang M,
Zheng L, Wang JH, Shi JF and Zhang XG: Altered CD28 and CD95 mRNA
expression in peripheral blood mononuclear cells from elderly
patients with primary non-small cell lung cancer. Chin Med J
(Engl). 123:51–56. 2010.PubMed/NCBI
|
|
7
|
Gratas C, Tohma Y, Barnas C, Taniere P,
Hainaut P and Ohgaki H: Up-regulation of Fas (APO-1/CD95) ligand
and down-regulation of Fas expression in human esophageal cancer.
Cancer Res. 58:2057–2062. 1998.PubMed/NCBI
|
|
8
|
Watson CJ, O'Kane H, Maxwell P, Sharaf O,
Petak I, Hyland PL, O'Rouke D, McKnight J, Canning P and Williamson
K: Identification of a methylation hotspot in the death receptor
Fas/CD95 in bladder cancer. Int J Oncol. 40:645–654.
2012.PubMed/NCBI
|
|
9
|
Heidari S, Akrami H, Gharaei R, Jalili A,
Mahdiuni H and Golezar E: Anti-tumor activity of ferulago angulata
boiss. Extract in gastric cancer cell line via induction of
apoptosis. Iran J Pharm Res. 13:1335–1345. 2014.PubMed/NCBI
|
|
10
|
Zhao ZG and Shen WL: Heat shock protein 70
antisense oligonucleotide inhibits cell growth and induces
apoptosis in human gastric cancer cell line SGC-7901. World J
Gastroenterol. 11:73–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Guo QL, You QD, Zhao L, Gu HY and
Yuan ST: Anticancer effect and apoptosis induction of gambogic acid
in human gastric cancer line BGC-823. World J Gastroenterol.
11:3655–3659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song MQ, Zhu JS, Chen JL, Wang L, Da W,
Zhu L and Zhang WP: Synergistic effect of oxymatrine and
angiogenesis inhibitor NM-3 on modulating apoptosis in human
gastric cancer cells. World J Gastroenterol. 13:1788–1793. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peter ME, Hadji A, Murmann AE, Brockway S,
Putzbach W, Pattanayak A and Ceppi P: The role of CD95 and CD95
ligand in cancer. Cell Death Differ. 22:885–886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Tong S, Guan L, Na F, Zhao W and
Wei L: CD95 rs1800682 polymorphism and cervical cancer risk:
Evidence from a meta-analysis. Tumour Biol. 35:1785–1790. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De la Rosa AJ, Gomez MA, Morales S,
Padillo FJ and Muntane J: CD95 signaling in cancer treatment. Curr
Pharm Des. 20:2809–2818. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li F, Liu Y, Fu T, Tong W and Zhang A:
Associations of three common polymorphisms in CD95 and CD95L
promoter regions with gastric cancer risk. Tumour Biol.
34:2293–2298. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martin-Villalba A, Llorens-Bobadilla E and
Wollny D: CD95 in cancer: Tool or target? Trends Mol Med.
19:329–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu J, Nihal M, Siddiqui J, Vonderheid EC
and Wood GS: Low FAS/CD95 expression by CTCL correlates with
reduced sensitivity to apoptosis that can be restored by FAS
upregulation. J Invest Dermatol. 129:1165–1173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lavrik IN, Golks A, Riess D, Bentele M,
Eils R and Krammer PH: Analysis of CD95 threshold signaling:
Triggering of CD95 (FAS/APO-1) at low concentrations primarily
results in survival signaling. J Biol Chem. 282:13664–13671. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yap R, Veliceasa D, Emmenegger U, Kerbel
RS, McKay LM, Henkin J and Volpert OV: Metronomic low-dose
chemotherapy boosts CD95-dependent antiangiogenic effect of the
thrombospondin peptide ABT-510: A complementation antiangiogenic
strategy. Clin Cancer Res. 11:6678–6685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCabe MJ Jr, Eckles KG, Langdon M,
Clarkson TW, Whitekus MJ and Rosenspire AJ: Attenuation of
CD95-induced apoptosis by inorganic mercury: Caspase-3 is not a
direct target of low levels of Hg2+. Toxicol Lett. 155:161–170.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strand S, Strand D, Seufert R, Mann A,
Lotz J, Blessing M, Lahn M, Wunsch A, Broering DC, Hahn U, et al:
Placenta-derived CD95 ligand causes liver damage in hemolysis,
elevated liver enzymes, and low platelet count syndrome.
Gastroenterology. 126:849–858. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takarada S, Imanishi T, Hano T and Nishio
I: Oxidized low-density lipoprotein sensitizes human vascular
smooth muscle cells to FAS (CD95)-mediated apoptosis. Clin Exp
Pharmacol Physiol. 30:289–294. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amendola A, Poccia F, Martini F, Gioia C,
Galati V, Pierdominici M, Marziali M, Pandolfi F, Colizzi V,
Piacentini M, et al: Decreased CD95 expression on naive T cells
from HIV-infected persons undergoing highly active anti-retroviral
therapy (HAART) and the influence of IL-2 low dose administration.
Irhan Study Group. Clin Exp Immunol. 120:324–332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Munker R, Younes A, Cabanillas F and
Andreeff M: Soluble CD95 in the serum of patients with low and
intermediate grade malignant lymphomas: Absence of prognostic
correlations. Leuk Lymphoma. 27:517–521. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elrod HA, Fan S, Muller S, Chen GZ, Pan L,
Tighiouart M, Shin DM, Khuri FR and Sun SY: Analysis of death
receptor 5 and caspase-8 expression in primary and metastatic head
and neck squamous cell carcinoma and their prognostic impact. PLoS
One. 5:e121782010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi LS, Wang H, Wang F, Feng M, Wang M and
Guan WX: Effects of gastrokine-2 expression on gastric cancer cell
apoptosis by activation of extrinsic apoptotic pathways. Mol Med
Rep. 10:2898–2904. 2014.PubMed/NCBI
|
|
29
|
Liu M, Li CM, Chen ZF, Ji R, Guo QH, Li Q,
Zhang HL and Zhou YN: Celecoxib regulates apoptosis and autophagy
via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer
cells. Int J Mol Med. 33:1451–1458. 2014.PubMed/NCBI
|
|
30
|
Stupack DG: Caspase-8 as a therapeutic
target in cancer. Cancer Lett. 332:133–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Medema JP, Scaffidi C, Kischkel FC,
Shevchenko A, Mann M, Krammer PH and Peter ME: FLICE is activated
by association with the CD95 death-inducing signaling complex
(DISC). EMBO J. 16:2794–2804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang
YC and Xin Y: Expression of Fas ligand and caspase-3 contributes to
formation of immune escape in gastric cancer. World J
Gastroenterol. 9:1415–1420. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nho RS, Peterson M, Hergert P and Henke
CA: FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic
Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized
collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.
PLoS One. 8:e610172013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu Q, Peng J, Liu W, He X, Cui L, Chen X,
Yang M, Liu H, Liu S and Wang H: Elevated cleaved caspase-3 is
associated with shortened overall survival in several cancer types.
Int J Clin Exp Pathol. 7:5057–5070. 2014.PubMed/NCBI
|
|
35
|
Ran X, Diao JX, Sun XG, Wang M, An H,
Huang GQ, Zhao XS, Ma WX, Zhou FH, Yang YG and Miao CM: Huangzhi
oral liquid prevents arrhythmias by upregulating caspase-3 and
apoptosis network proteins in myocardial ischemia-reperfusion
injury in rats. Evid Based Complement Alternat Med.
2015:5189262015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hua RX, Li HP, Liang YB, Zhu JH, Zhang B,
Ye S, Dai QS, Xiong SQ, Gu Y and Sun XZ: Association between the
PARP1 Val762Ala polymorphism and cancer risk: Evidence from 43
studies. PLoS One. 9:e870572014. View Article : Google Scholar : PubMed/NCBI
|
